Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q1 2023 · 10-Q
Revenue$277.06M$277.06M+2.9% vs Q1 2022 Net Income$55.27M$55.27M−4.3% vs Q1 2022 EPS Diluted$1.09$1.09−4.4% vs Q1 2022 Gross Profit$160,119,000+0.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flow$58,247,000−16.0% Free Cash Flowderived$57,200,000−15.6% Margins · derivedGross margin57.8%−1.3 pt vs Q1 2022
Operating margin31.4%−2.5 pt vs Q1 2022
Net margin19.9%−1.5 pt vs Q1 2022
ended Jun 30, 2022 · filed Aug 4, 2022 · 35 d after period end